Affiliations 

  • 1 Universiti Kebangsaan Malaysia, Faculty of Medicine, Department of Pathology, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur, Malaysia
  • 2 Women's and Children's Hospital, Department of Pathology, SA Pathology, North Adelaide, SA 5006, Australia
  • 3 Universiti Kebangsaan Malaysia, Faculty of Medicine, Department of Pathology, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur, Malaysia. ypwong@ppukm.ukm.edu.my
  • 4 Universiti Kebangsaan Malaysia, Faculty of Medicine, Department of Pathology, Jalan Yaacob Latif, Bandar Tun Razak, Kuala Lumpur, Malaysia. tangc@ppukm.ukm.edu.my
Malays J Pathol, 2023 Dec;45(3):353-362.
PMID: 38155377

Abstract

INTRODUCTION: Hydatidiform mole is one of the gestational trophoblastic disease and comprises complete (CM) and partial moles (PM), which carries a risk of developing persistence disease, invasive mole or choriocarcinoma. MicroRNAs (miRNAs) have been discovered in various tissues, including neoplastic tissues. Its role in the pathogenesis of molar pregnancy or as biomarkers are still largely uncertain. The aim of this study is to identify the differentially expressed miRNAs in CM and PM.

MATERIALS AND METHODS: Using next-generation sequencing, the miRNAs profiles of CM (n=3) and PM (n=3) moles, including placenta of non-molar abortus (n=3) as control were determined. The differentially expressed miRNAs between each group were analysed. Subsequently, bioinformatics analysis using miRDB and Targetscan was utilised to predict target genes.

RESULTS: We found 10 differentially expressed miRNAs in CMs and PMs, compared to NMAs, namely miR- 518a-5p, miR-423-3p, miR-503-5p, miR-302a-3p, and miR-1323. The other 5 miRNAs were novel, not listed in the known database. The 3 differentially expressed miRNAs in CMs were predicted to commonly target ZTBT46 and FAM73B mRNAs.

DISCUSSION: miR-518 was consistently observed to be downregulated in CM versus PM, and CM versus NMA. Further bioinformatic analysis to provide insight into the possible role of these miRNAs in the pathogenesis of HMs, progression of disease and as potential diagnostic biomarkers as well as therapeutic targets for HMs is needed.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.